DUBLIN--(BUSINESS WIRE)--The "Global Animal Pharmaceuticals Market (2021-2026) by Type, Product, End-User, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.
The Global Animal Pharmaceuticals Market is estimated to be USD 19.3 Bn in 2021 and is expected to reach USD 28.16 Bn by 2026, growing at a CAGR of 7.85%.
Market Dynamics
The global animal pharmaceuticals market is being driven by rising milk and meat consumption, the rising trend of pet adoption, and the rising prevalence of foodborne and zoonotic illnesses. Animals are adopted for companionship or as a house or workplace security, which has made animals an essential aspect of human existence in our day.
Therefore it's necessary to look after their well-being and health. As a result, the deeper bond between humans and animals and the rising demand for pets are all driving the animal pharmaceuticals industry forward. In addition, as the economies are growing, governments and pharmaceutical firms are investing in animal healthcare, creating new opportunities for the market ahead.
However, the market's development is being restrained by rising costs and the government regulatory prohibitions on the animal pharmaceuticals industry.
Recent Developments
- Elanco announces an agreement to acquire Kindred Biosciences for the expansion in pet health. - 16th June 2021.
- Phibro Animal Health Corporation Acquires Business of Osprey Biotechnics, Inc.- 1st August 2019.
Company Profiles
Some of the companies covered in this report are Aratana Therapeutics, Inc., Bayer AG, BioPredic International, Boehringer Ingelheim International GmbH, etc.
Key Topics Covered:
1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Shareholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.3 Market Size Estimation
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size and Segmentation
3.3 Market Outlook
4 Market Influencers
4.1 Drivers
4.1.1 Growing Adoption of Pets
4.1.2 Increasing Population of Livestock
4.1.3 Government Obligatory Medication and Vaccination
4.2 Restraints
4.2.1 Numerous Risk Associated with Animal Health APIs
4.3 Opportunities
4.3.1 Rising Expenditure for Animal Healthcare
4.3.2 Introduction of New Products
4.4 Challenges
4.4.1 Inadequate Knowledge and Availability in Low-Income Areas
4.5 Trends
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 Global Animal Pharmaceuticals Market, By Type
6.1 Introduction
6.2 Vaccine
6.3 Veterinary Drugs
7 Global Animal Pharmaceuticals Market, By Product
7.1 Introduction
7.2 Anti-Inflammatories
7.3 Bronchodilators
7.4 Ectoparasiticides
7.5 Endoparasiticides
8 Global Animal Pharmaceuticals Market, By End User
8.1 Introduction
8.2 Hospitals
8.3 Laboratories
8.4 Veterinary Clinics
9 Global Animal Pharmaceuticals Market, By Geography
10 Competitive Landscape
10.1 Competitive Quadrant
10.2 Market Share Analysis
10.3 Strategic Initiatives
11 Company Profiles
- Aratana Therapeutics, Inc
- Bayer AG
- BioPredic International
- Bimeda Animal Health Ltd
- Boehringer Ingelheim International GmbH
- Ceva Sante Animale
- Dechra Veterinary Products USA
- Elanco Animal Health Inc.
- Eli Lilly & Company
- Huvepharma, Inc.
- Liberty Pharma INC
- Merck & Co., Inc.
- Perrigo Company plc
- Phibro Animal Health Corp
- Sanofi
- Sparhawk Laboratories
- Vetoquinol S.A.
- Virbac SA
- Zoetis Inc
For more information about this report visit https://www.researchandmarkets.com/r/abuhn6
